Posts tagged ‘oncology’

It’s a sad story that everyone is familiar with: A patient takes one or more well-known cancer drugs, and they work – for a while. However, after...

This is Part 2 in a three-part series on patient-centered outcomes. (Check out Part 1 and Part 3). A personalized medicine approach to clinical...

This is Part 1 in a three-part series on patient-centered outcomes. (Check out Part 2 and Part 3). In different regulatory and research settings...

This month Drug Discovery News published Dr. Kevin Lustig’s editorial discussing how outsourcing is a viable strategy for advancing oncology...

An oncogene is a gene that can potentially cause cancer. RAS is a common class of oncogene and the focus of researchers worldwide, particularly at...

As previously discussed, there is great value in using in vivo models such as genetically modified mice and xenograft models for oncology research...

Xenograft is animal tissue implanted into a different species and is often used for evaluating treatment for disease and organ failure. Currently...

Oncology research using genetically engineered mice (GEM) to express oncogenes and model cancers has grown exponentially in the past 30 years...